Article Versions Notes

Elkaeed EB, Elkady H, Belal A, Alsfouk BA, Ibrahim TH, Abdelmoaty M, Arafa RK, Metwaly AM, Eissa IH. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022; 10(3):530. https://doi.org/10.3390/pr10030530

Elkaeed, Eslam B., Hazem Elkady, Amany Belal, Bshra A. Alsfouk, Tuqa H. Ibrahim, Mohamed Abdelmoaty, Reem K. Arafa, Ahmed M. Metwaly, and Ibrahim H. Eissa. 2022. "Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs" Processes 10, no. 3: 530. https://doi.org/10.3390/pr10030530

Elkaeed, E. B., Elkady, H., Belal, A., Alsfouk, B. A., Ibrahim, T. H., Abdelmoaty, M., Arafa, R. K., Metwaly, A. M., & Eissa, I. H. (2022). Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes, 10(3), 530. https://doi.org/10.3390/pr10030530